Dose-ranging Study: Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers in Ghana
Clinical trial NCT04093076 · COMPLETED
Trial details
- NCT number
- NCT04093076
- Sponsor
- Inovio Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-27
- Primary completion
- 2022-10-14
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.